Taiwan FDA registration b26400b8f85815c5a99fee3dc5b61c67
KatiaTM Anti-Nuclear Antibody Detection Set
TW: 卡蒂雅TM 抗細胞核抗體檢測試劑組
Taiwan·Risk Class 2·TRINITY BIOTECH USA·Registered Aug 10, 2006 – Aug 10, 2011CancelledRegistration details
- Analysis ID
- b26400b8f85815c5a99fee3dc5b61c67
- Customs Code
- DHA00601727106
Company information
- Manufacturer
- TRINITY BIOTECH USA
- Manufacturer Country
- United States
- Authorized Representative
- GRAND MARQUIS CO., LTD.
Product details
- Intended Use
- Enzyme immunosorption assay was used to detect anti-nuclear antibodies in human serum.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5100 抗核抗體免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Aug 10, 2006
- Expiry Date
- Aug 10, 2011
- Cancellation Date
- Nov 27, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for KatiaTM Anti-Nuclear Antibody Detection Set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b26400b8f85815c5a99fee3dc5b61c67 and manufactured by TRINITY BIOTECH USA. The authorized representative in Taiwan is GRAND MARQUIS CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices